Loading...
Xylem Inc (XYL) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. Despite recent price weakness and mixed guidance, the company's strong financial performance, positive long-term growth outlook, and valuation discount make it a compelling opportunity.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish, suggesting short-term weakness. The stock is trading near its pivot level of 128.616, with key support at 126.11 and resistance at 131.122.

BNP Paribas highlights a valuation discount, presenting a buying opportunity.
Strong core margin expansion supported by operational initiatives and favorable industrial market exposure.
Double-digit earnings growth expected through 2026.
Mixed Q4 results with weaker-than-expected guidance for Q1 and FY
Concerns about peaking demand and funding risks as noted by analysts.
Weakness in China and project delays impacting near-term performance.
In Q4 2025, revenue increased by 6.25% YoY to $2.397 billion, net income grew by 2.76% YoY to $335 million, and EPS rose by 2.24% YoY to $1.37. Gross margin improved to 38.88%, up 2.34% YoY, indicating solid operational performance.
Analysts maintain a generally positive outlook on Xylem, with multiple Buy and Outperform ratings. However, price targets have been lowered recently, reflecting concerns about near-term guidance and sector challenges. The average price target remains above the current price, suggesting upside potential.